Insulin
Revision as of 08:38, 12 March 2011 by Rossdonaldson1 (talk | contribs)
| Type | Onset of action (h) | Peak action | Effective duration | Max duration |
| RAPID ACTING | ||||
|
Lispro (humalog) |
0.25-0.5 |
0.5-1.25 | 3-4 | 4-6 |
|
Aspart (novolog) |
0.25-0.5 |
0.5-1.25 | 3-4 | 4-6 |
|
Glulisine (apidra) |
0.25-0.5 | 0.25-1.25 |
3-4 | 4-6 |
| SHORT ACTING | ||||
| Regular | 0.5-1 | 2-3 | 3-6 | 6-8 |
| INTERMEDIATE ACTING | ||||
| NPH | 2-4 | 6-10 | 10-16 | 14-18 |
| LONG ACTING | ||||
|
glargine (Lantus) |
3-4 | 8-16 | 18-20 | 20-24 |
|
detemir (Levemir) |
3-4 | 6-8 | 14 | ~20 |
Type Onset of action (h) Peak action Effective duration Max duration
RAPID ACTING
Lispro
(humalog)
0.25-0.5 0.5-1.25 3-4 4-6 Aspart
(novolog)
0.25-0.5 0.5-1.25 3-4 4-6 Glulisine
(apidra)
0.25-0.5 0.25-1.25 3-4 4-6 SHORT ACTING Regular 0.5-1 2-3 3-6 6-8 INTERMEDIATE ACTING NPH 2-4 6-10 10-16 14-18 LONG ACTING glargine
(Lantus)
3-4 8-16 18-20 20-24 detemir
(Levemir)
3-4 6-8 14 ~20